Tag:
elagolix
Latest Headlines
Latest Headlines
Neurocrine banks $20M as endometriosis drug advances to PhIII
Abbott Labs and Neurocrine Biosciences ( $NBIX ) recently sat down with FDA regulators to outline plans for a late-stage study of their experimental endometriosis drug elagolix , triggering a $20
On a roll, Neurocrine nails $575M licensing deal with Abbott
Hot on the heels of a promising package of top-line results from the Phase II trial of their endometriosis therapy, Neurocrine Biosciences ( NBIX ) has wrapped a $575 million licensing deal for the
Neurocrine shares skyrocket on promising PhII endometriosis data
Shares of Neurocrine Biosciences soared more than 50 percent in after-markets trading after the San Diego-based developer spelled out the success of a mid-stage trial of elagolix in a population of
